The combined effect of green tea and α-glucosyl hesperidin in preventing obesity: a randomized placebo-controlled clinical trial
Abstract Green tea, a widely consumed beverage in Asia, contains green tea catechins effective against obesity, especially epigallocatechin-3-O-gallate (EGCG), but must be consumed in an impractically huge amount daily to elicit its biological effect. Meanwhile, citrus polyphenols have various physi...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b004c9b816d54e02a615ab529606f01b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:b004c9b816d54e02a615ab529606f01b |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:b004c9b816d54e02a615ab529606f01b2021-12-02T17:27:03ZThe combined effect of green tea and α-glucosyl hesperidin in preventing obesity: a randomized placebo-controlled clinical trial10.1038/s41598-021-98612-62045-2322https://doaj.org/article/b004c9b816d54e02a615ab529606f01b2021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-98612-6https://doaj.org/toc/2045-2322Abstract Green tea, a widely consumed beverage in Asia, contains green tea catechins effective against obesity, especially epigallocatechin-3-O-gallate (EGCG), but must be consumed in an impractically huge amount daily to elicit its biological effect. Meanwhile, citrus polyphenols have various physiological effects that could enhance EGCG functionality. Here we investigated the antiobesity effect of a combination of EGCG and α-glucosyl hesperidin, a citrus polyphenol, at doses that have not been previously reported to exert antiobesity effects by themselves in any clinical trial. In a randomized, placebo-controlled, double-blinded, and parallel-group-designed clinical trial, 60 healthy Japanese males and females aged 30–75 years consumed green tea combined with α-glucosyl hesperidin (GT-gH), which contained 178 mg α-glucosyl hesperidin and 146 mg EGCG, for 12 weeks. Physical, hematological, blood biochemical, and urine examinations showed that GT-gH is safe to use. At week 12, GT-gH prevented weight gain and reduced body mass index (BMI) compared with the placebo. Especially in those aged < 50 years, triglyceride and body fat percentage decreased at week 6, visceral fat level and body fat percentage decreased at week 12; body weight, BMI, and blood LDL/HDL ratio also decreased. In conclusion, taking GT-gH prevents weight gain, and the antiobesity effect of GT-gH was more pronounced in people aged < 50 years.Ren YoshitomiMao YamamotoMotofumi KumazoeYoshinori FujimuraMadoka YonekuraYasuyo ShimamotoAkari NakasoneSatoshi KondoHiroki HattoriAkane HasedaJun NishihiraHirofumi TachibanaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Ren Yoshitomi Mao Yamamoto Motofumi Kumazoe Yoshinori Fujimura Madoka Yonekura Yasuyo Shimamoto Akari Nakasone Satoshi Kondo Hiroki Hattori Akane Haseda Jun Nishihira Hirofumi Tachibana The combined effect of green tea and α-glucosyl hesperidin in preventing obesity: a randomized placebo-controlled clinical trial |
description |
Abstract Green tea, a widely consumed beverage in Asia, contains green tea catechins effective against obesity, especially epigallocatechin-3-O-gallate (EGCG), but must be consumed in an impractically huge amount daily to elicit its biological effect. Meanwhile, citrus polyphenols have various physiological effects that could enhance EGCG functionality. Here we investigated the antiobesity effect of a combination of EGCG and α-glucosyl hesperidin, a citrus polyphenol, at doses that have not been previously reported to exert antiobesity effects by themselves in any clinical trial. In a randomized, placebo-controlled, double-blinded, and parallel-group-designed clinical trial, 60 healthy Japanese males and females aged 30–75 years consumed green tea combined with α-glucosyl hesperidin (GT-gH), which contained 178 mg α-glucosyl hesperidin and 146 mg EGCG, for 12 weeks. Physical, hematological, blood biochemical, and urine examinations showed that GT-gH is safe to use. At week 12, GT-gH prevented weight gain and reduced body mass index (BMI) compared with the placebo. Especially in those aged < 50 years, triglyceride and body fat percentage decreased at week 6, visceral fat level and body fat percentage decreased at week 12; body weight, BMI, and blood LDL/HDL ratio also decreased. In conclusion, taking GT-gH prevents weight gain, and the antiobesity effect of GT-gH was more pronounced in people aged < 50 years. |
format |
article |
author |
Ren Yoshitomi Mao Yamamoto Motofumi Kumazoe Yoshinori Fujimura Madoka Yonekura Yasuyo Shimamoto Akari Nakasone Satoshi Kondo Hiroki Hattori Akane Haseda Jun Nishihira Hirofumi Tachibana |
author_facet |
Ren Yoshitomi Mao Yamamoto Motofumi Kumazoe Yoshinori Fujimura Madoka Yonekura Yasuyo Shimamoto Akari Nakasone Satoshi Kondo Hiroki Hattori Akane Haseda Jun Nishihira Hirofumi Tachibana |
author_sort |
Ren Yoshitomi |
title |
The combined effect of green tea and α-glucosyl hesperidin in preventing obesity: a randomized placebo-controlled clinical trial |
title_short |
The combined effect of green tea and α-glucosyl hesperidin in preventing obesity: a randomized placebo-controlled clinical trial |
title_full |
The combined effect of green tea and α-glucosyl hesperidin in preventing obesity: a randomized placebo-controlled clinical trial |
title_fullStr |
The combined effect of green tea and α-glucosyl hesperidin in preventing obesity: a randomized placebo-controlled clinical trial |
title_full_unstemmed |
The combined effect of green tea and α-glucosyl hesperidin in preventing obesity: a randomized placebo-controlled clinical trial |
title_sort |
combined effect of green tea and α-glucosyl hesperidin in preventing obesity: a randomized placebo-controlled clinical trial |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/b004c9b816d54e02a615ab529606f01b |
work_keys_str_mv |
AT renyoshitomi thecombinedeffectofgreenteaandaglucosylhesperidininpreventingobesityarandomizedplacebocontrolledclinicaltrial AT maoyamamoto thecombinedeffectofgreenteaandaglucosylhesperidininpreventingobesityarandomizedplacebocontrolledclinicaltrial AT motofumikumazoe thecombinedeffectofgreenteaandaglucosylhesperidininpreventingobesityarandomizedplacebocontrolledclinicaltrial AT yoshinorifujimura thecombinedeffectofgreenteaandaglucosylhesperidininpreventingobesityarandomizedplacebocontrolledclinicaltrial AT madokayonekura thecombinedeffectofgreenteaandaglucosylhesperidininpreventingobesityarandomizedplacebocontrolledclinicaltrial AT yasuyoshimamoto thecombinedeffectofgreenteaandaglucosylhesperidininpreventingobesityarandomizedplacebocontrolledclinicaltrial AT akarinakasone thecombinedeffectofgreenteaandaglucosylhesperidininpreventingobesityarandomizedplacebocontrolledclinicaltrial AT satoshikondo thecombinedeffectofgreenteaandaglucosylhesperidininpreventingobesityarandomizedplacebocontrolledclinicaltrial AT hirokihattori thecombinedeffectofgreenteaandaglucosylhesperidininpreventingobesityarandomizedplacebocontrolledclinicaltrial AT akanehaseda thecombinedeffectofgreenteaandaglucosylhesperidininpreventingobesityarandomizedplacebocontrolledclinicaltrial AT junnishihira thecombinedeffectofgreenteaandaglucosylhesperidininpreventingobesityarandomizedplacebocontrolledclinicaltrial AT hirofumitachibana thecombinedeffectofgreenteaandaglucosylhesperidininpreventingobesityarandomizedplacebocontrolledclinicaltrial AT renyoshitomi combinedeffectofgreenteaandaglucosylhesperidininpreventingobesityarandomizedplacebocontrolledclinicaltrial AT maoyamamoto combinedeffectofgreenteaandaglucosylhesperidininpreventingobesityarandomizedplacebocontrolledclinicaltrial AT motofumikumazoe combinedeffectofgreenteaandaglucosylhesperidininpreventingobesityarandomizedplacebocontrolledclinicaltrial AT yoshinorifujimura combinedeffectofgreenteaandaglucosylhesperidininpreventingobesityarandomizedplacebocontrolledclinicaltrial AT madokayonekura combinedeffectofgreenteaandaglucosylhesperidininpreventingobesityarandomizedplacebocontrolledclinicaltrial AT yasuyoshimamoto combinedeffectofgreenteaandaglucosylhesperidininpreventingobesityarandomizedplacebocontrolledclinicaltrial AT akarinakasone combinedeffectofgreenteaandaglucosylhesperidininpreventingobesityarandomizedplacebocontrolledclinicaltrial AT satoshikondo combinedeffectofgreenteaandaglucosylhesperidininpreventingobesityarandomizedplacebocontrolledclinicaltrial AT hirokihattori combinedeffectofgreenteaandaglucosylhesperidininpreventingobesityarandomizedplacebocontrolledclinicaltrial AT akanehaseda combinedeffectofgreenteaandaglucosylhesperidininpreventingobesityarandomizedplacebocontrolledclinicaltrial AT junnishihira combinedeffectofgreenteaandaglucosylhesperidininpreventingobesityarandomizedplacebocontrolledclinicaltrial AT hirofumitachibana combinedeffectofgreenteaandaglucosylhesperidininpreventingobesityarandomizedplacebocontrolledclinicaltrial |
_version_ |
1718380808136294400 |